Search
Animal Welfare through environmental sustainability
Producing honey and contributing to environmental sustainability during your work hours.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks have reached the news.
COVID-19: Global Support Program - Global
COVID-19: Global Support Program - Oceania
COVID-19: Global Support Program - Middle East & Africa
COVID-19: Global Support Program - Asia
COVID-19: Global Support Program - The Americas
COVID-19: Global Support Program - Europe
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
Labor & Human Rights
Suppliers shall support and respect the protection of internationally proclaimed human rights.
The Supplier Code of Conduct
BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements.
Cattle well-being at farms’ core
From pain management to responsible use of antibiotics, Cattle First introduces a whole cow approach to look after health and productivity.
Retinal health
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in Retinal Health.
Retinal Health Research
Read about our holistic approach to retinal health research.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim partially offsets its carbon emissions by partnering with ClimateSeed
View from Both Sides of the Table
Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care
Disentangling fibrosis
Fibrosis is an important area of research for Boehringer Ingelheim that is focusing on fibrotic conditions of the liver, lung, kidney, skin and gut.
Submit Your Opportunity
Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team
Our Curiosity Never Stops
Dr. Cornelia Dorner-Ciossek shares her thoughts on the future of brain disease research.
Looking behind the scenes of Afrika Kommt!
Looking behind the scenes of Afrika Kommt! with Sabine and Eunice. I in D&I audio interview with reflections on a program designed to build bridges.
China pioneers biosecurity report against ASF
Boehringer Ingelheim compiles data from 1,000 swine farms into the first market report on biosecurity. Document sheds light on livestock management and contributes to the fight against African swine fever.
Cancer's Big 4
Cancers’ big 4 targets (RAS, p53, MYC, beta-catenin) have previously been considered ‘undruggable’, we are working hard to challenge this belief.
Immuno-Oncology
We are unlocking the broader possibilities of immuno-oncology, taking cancer on through the power of the body’s immune system.